DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Sincalide

Sincalide

  • [Product Monograph Template

    [Product Monograph Template

  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

    Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

  • Chapter 12 Monographs of 99Mtc Pharmaceuticals 12

    Chapter 12 Monographs of 99Mtc Pharmaceuticals 12

  • (12) United States Patent (10) Patent No.: US 6,803,046 B2 Metcalfe Et Al

    (12) United States Patent (10) Patent No.: US 6,803,046 B2 Metcalfe Et Al

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • Drugs and Biologicals Fee Schedule

    Drugs and Biologicals Fee Schedule

  • Foi-276-1213-02.Pdf

    Foi-276-1213-02.Pdf

  • Drugs Used As Interventional Agents in Nuclear Medicine

    Drugs Used As Interventional Agents in Nuclear Medicine

  • ( N Am Am Pm Vpm 17 16

    ( N Am Am Pm Vpm 17 16

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • List of Pharamaceutical Peptides Available from ADI

    List of Pharamaceutical Peptides Available from ADI

  • USP Endotoxin Limits for Common Injectables

    USP Endotoxin Limits for Common Injectables

  • (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr

    (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr

  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

    Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021

    FDA Listing of Established Pharmacologic Class Text Phrases January 2021

  • Ibm Micromedex® Carenotes Titles by Category

    Ibm Micromedex® Carenotes Titles by Category

  • Use of Cholecystokinin to Prevent the Development of Parenteral Nutrition-Associated Cholestasis*

    Use of Cholecystokinin to Prevent the Development of Parenteral Nutrition-Associated Cholestasis*

  • Development of Novel Transdermal Drug Delivery Technologies for Therapeutic Peptides

    Development of Novel Transdermal Drug Delivery Technologies for Therapeutic Peptides

Top View
  • Appendix B - Product Name Sorted by Applicant
  • Wednesday, April 8, 2015 4 P.M
  • FOI 169-1415 Document 4
  • 2019 Table of Drugs
  • Wednesday, March 13, 2019 4:00Pm
  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
  • Potency Price List
  • Gpi Drug Classification Report
  • HCPCS/Drug Code List Version 12.2 Revised 11/22/19 List Will Be Updated Routinely Go to Data.Medicaid.Gov for a Complete List Of
  • Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
  • Wo 2007/044693 A2
  • Product Monograph
  • WO 2015/167760 Al 5 November 2015 (05.11.2015) P O P C T
  • Clinical PET and PET/CT PETCT PRE(I-X).Qxd 23/10/04 11:19 AM Page Iii
  • 2008 Table of Drugs
  • Authorization Requirements for Medications Under the Kentucky Medicaid Prescription Benefit
  • Mesh Terms for 2002
  • CPT Copyright 2019 American Medical Association. All Rights Reserved


© 2024 Docslib.org    Feedback